Beta Bionics, Inc. (BBNX)
19.42
-0.50
(-2.51%)
USD |
NASDAQ |
Sep 04, 16:00
19.41
-0.01
(-0.05%)
After-Hours: 20:00
Beta Bionics Debt to Equity Ratio : 0.0254 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0254 |
| March 31, 2026 | 0.0255 |
| December 31, 2025 | 0.0254 |
| September 30, 2025 | 0.0261 |
| June 30, 2025 | 0.0222 |
| March 31, 2025 | 0.0222 |
| Date | Value |
|---|---|
| December 31, 2024 | 0.0954 |
| September 30, 2024 | 0.2221 |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | 0.0721 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Enovis Corp. | 0.9269 |
| Edwards Lifesciences Corp. | 0.0663 |
| Intuitive Surgical, Inc. | 0.00 |
| Kewaunee Scientific Corp. | 0.7604 |
| STAAR Surgical Co. | 0.0984 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 292.39M |
| Total Liabilities (Quarterly) | 36.02M |
| Shareholders Equity (Quarterly) | 256.37M |
| Current Ratio | 8.880 |
| Net Debt Paydown Yield | 0.01% |